Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mucositis × Imatinib Mesylate × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72 Leukemia 38 Gastrointestinal Stromal Tumors 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Leukemia, Myeloid, Chronic-Phase 26 Blast Crisis 11 Brain Neoplasms 10 Neoplasms 9 Neoplasm Metastasis 9 Melanoma 9 Lung Neoplasms 9 Gliosarcoma 8 Glioblastoma 8 Prostatic Neoplasms 7 Leukemia, Myeloid, Acute 7 Leukemia, Myeloid, Accelerated Phase 6 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Philadelphia Chromosome 5 Oligodendroglioma 5 Primary Myelofibrosis 4 Head and Neck Neoplasms 4 Central Nervous System Neoplasms 4 Astrocytoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Recurrence 3 Polycythemia Vera 3 Pancreatic Neoplasms 3

Interventions

Radiation 4 Radiotherapy 3 Propolis 3 Morphine 3 Low-Level Light Therapy 3 Cisplatin 3 Probiotics 2 Pentoxifylline 2 Mouthwashes 2 Methotrexate 2 Melphalan 2 Leucovorin 2 Interleukin 1 Receptor Antagonist Protein 2 Honey 2 Gabapentin 2 Fluorouracil 2 Fibroblast Growth Factor 7 2 Drug Therapy 2 Cryotherapy 2 Amifostine 2 peppermint oil 1 pegfilgrastim 1 pegaspargase 1 oxycodone-acetaminophen 1 nelarabine 1 maltodextrin 1 kang-lai-te 1 glucarpidase 1 fludarabine phosphate 1 fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡